IP Library › Assignment 074946/0177
Patent Assignment
Reel/Frame 074946/0177

Assignment of Assignor's Interest

Recorded: 2026-02-20 Pages: 35
Assignors
OXFORD FINANCE LLC
Executed: 2025-08-21
EFFECTOR THERAPEUTICS, INC.
Executed: 2025-08-21
Assignee
SJP BIOTEC GMBH
SEESTRASSE 880, MEILEN, ZURICH, 8706, SWITZERLAND
Covered Properties (59)
Mnk Inhibitors and Methods Related Thereto
Application: 15/809,011 →
Publication: US 2018/0085368
Mnk Inhibitors and Methods Related Thereto
Application: 16/178,678 →
Publication: US 2019/0209560
Mnk Inhibitors and Methods Related Thereto
Application: 17/308,486 →
Publication: US 2021/0338673
Mnk Inhibitors and Methods Related Thereto
Application: 62/017,112 →
Isoindoline, Azaisoindoline, Dihydroindenone and Dihydroazaindenone Inhibitors of MNK1 and MNK2
Application: 16/171,606 →
Publication: US 2019/0152988
Isoindoline, Azaisoindoline, Dihydroindenone and Dihydroazaindenone Inhibitors of MNK1 and MNK2
Application: 62/247,953 →
Pyrrolo-, Pyrazolo-, Imidazo-Pyrimidine and Pyridine Compounds That Inhibit MNK1 and MNK2
Application: 15/337,237 →
Publication: US 2017/0121339
Pyrrolo-, Pyrazolo-, Imidazo-Pyrimidine and Pyridine Compounds That Inhibit MNK1 and MNK2
Application: 62/247,966 →
Heterocyclic Compounds That Inhibit the Kinase Activity of Mnk Useful for Treating Various Cancers
Application: 62/258,096 →
Modified Natural Product Compounds Used as EIF4A Inhibitors
Application: 62/259,828 →
EIF4A-Inhibiting Compounds and Methods Related Thereto
Application: 62/334,149 →
EIF4E-Inhibiting Compounds and Methods Related Thereto
Application: 62/869,662 →
Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto
Application: 15/895,523 →
Publication: US 2018/0228803
Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto
Application: 62/458,671 →
Benzimidazole-Indole Inhibitors of MNK1 and MNK2
Application: 62/574,432 →
Crystalline Forms of Mnk Inhibitors
Application: 62/749,820 →
Use of Translational Profiling to Identify Target Molecules for Therapeutic Treatment
Application: 14/175,736 →
Publication: US 2014/0243356
Use of Translational Profiling to Identify Target Molecules for Therapeutic Treatment
Application: 14/176,018 →
Publication: US 2014/0288097
Use of Translational Profiling to Identify Target Molecules for Therapeutic Treatment
Application: 16/158,669 →
Publication: US 2019/0093170
Use of Translational Profiling to Identify Target Molecules for Therapeutic Treatment
Application: 16/160,820 →
Publication: US 2019/0136321
Use of Translational Profiling to Identify Target Molecules for Therapeutic Treatment
Application: 61/762,115 →
Compositions and Methods for Treating Fibrotic Disease
Application: 61/937,272 →
Compositions and Methods for Treating Fibrotic Disease
Application: 62/010,004 →
Compositions and Methods for Treating Fibrotic Disease
Application: 62/037,497 →
Compositions and Methods for Treating Neurological Disorders
Application: 15/114,277 →
Publication: US 2017/0247692
Compositions and Methods for Treating Neurological Disorders
Application: 61/937,315 →
Inhibitors of Immune Checkpoint Modulators and Related Methods
Application: 16/910,921 →
Publication: US 2021/0046074
Inhibitors of Immune Checkpoint Modulators and Related Methods
Application: 62/150,140 →
Inhibitors of Immune Checkpoint Modulators and Related Methods
Application: 62/260,917 →
Mnk Biomarkers and Uses Thereof
Application: 15/389,822 →
Publication: US 2017/0191136
Mnk Biomarkers and Uses Thereof
Application: 16/881,193 →
Publication: US 2021/0010086
Mnk Biomarkers and Uses Thereof
Application: 62/273,875 →
Methods and Compositions for Cellular Immunotherapy
Application: 62/510,680 →
Methods and Compositions for Cellular Immunotherapy
Application: 62/657,564 →
Compositions and Methods for an Improved Antitumor Immune Response
Application: 62/510,643 →
Methods of Treating Braf-Mutated Cancer Cells
Application: 17/624,504 →
Publication: US 2022/0378821
Methods of Treating Braf-Mutated Cancer Cells
Application: 62/869,894 →
EIF4E Inhibitors for Use as Immune Checkpoint Modulators and Related Methods
Application: 62/869,892 →
EIF4A Inhibitor Combinations
Application: 17/210,062 →
Publication: US 2021/0299111
EIF4A Inhibitor Combinations
Application: 62/993,889 →
Mnk Inhibitors and Methods Related Thereto
Isoindoline, Azaisoindoline, Dihydroindenone and Dihydroazaindenone Inhibitors of MNK1 and MNK2
Pyrrolo-, Pyrazolo-, Imidazo-Pyrimidine and Pyridine Compounds That Inhibit MNK1 and MNK2
Heterocyclic Compounds That Inhibit the Kinase Activity of Mnk Useful for Treating Various Cancers
EIF4-A-Inhibiting Compounds and Methods Related Thereto
EIF4E-Inhibiting Compounds and Methods
Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto
Benzimidazole-Indole Inhibitors of MNK1 and MNK2
Crystalline Forms of Mnk Inhibitors
Use of Translational Profiling to Identify Target Molecules for Therapeutic Treatment
Compositions and Methods for Treating Fibrotic Disease
Compositions and Methods for Treating Neurological Disorders
Inhibitors of Immune Checkpoint Modulators and Related Methods
Mnk Biomarkers and Uses Thereof
Methods and Compositions for Cellular Immunotherapy
Compositions and Methods for an Improved Antitumor Immune Response
Methods of Treating Braf-Mutated Cancer Cells
EIF4E Inhibitors for Use as Immune Checkpoint Modulators and Related Methods
EIF4A Inhibitor Combinations
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 3, 2013
From: RUGGERO, DAVIDE; HSIEH, ANDREW C.; EDLIND, MERRITT
To: THE REGENTS OF THE UNIVERISTY OF CALIFORNIA
Reel/Frame 030349/0185 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 030349 Frame 0185. Assignor(S) Hereby Confirms the Correct Name of the Assignee Is the Regents of the University of California. Jun 20, 2014
From: RUGGERO, DAVIDE; HSIEH, ANDREW C.; EDLIND, MERRITT
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 033205/0178 →
Assignment of Assignor's Interest Jul 8, 2014
From: APPLEMAN, JAMES; THOMPSON, PEGGY A.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 033259/0739 →
Assignment of Assignor's Interest Jul 8, 2014
From: APPLEMAN, JAMES; THOMPSON, PEGGY A.; HUANG, VERA
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 033259/0722 →
Assignment of Assignor's Interest Aug 5, 2014
From: REICH, SIEGFRIED H.; SPRENGELER, PAUL A.; WEBBER, STEPHEN E.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 033465/0455 →
Assignment of Assignor's Interest Nov 20, 2014
From: RUGGERO, DAVIDE; HSIEH, ANDREW; EDLIND, MERRITT
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 034224/0321 →
Assignment of Assignor's Interest Nov 21, 2014
From: RUGGERO, DAVIDE; HSIEH, ANDREW; EDLIND, MERRITT; SHOKAT, KEVAN M.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 034228/0661 →
Assignment of Assignor's Interest Nov 21, 2014
From: APPLEMAN, JAMES; WORLAND, STEVE
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 034228/0778 →
Assignment of Assignor's Interest Feb 4, 2015
From: APPLEMAN, JAMES; THOMPSON, PEGGY A.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 034888/0129 →
Assignment of Assignor's Interest Feb 4, 2015
From: APPLEMAN, JAMES; THOMPSON, PEGGY A.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 034888/0174 →
Assignment of Assignor's Interest Jun 17, 2015
From: WEBSTER, KEVIN R.; GOEL, VIKAS
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 035855/0283 →
Assignment of Assignor's Interest Sep 4, 2015
From: REICH, SIEGFRIED H.; SPRENGELER, PAUL A.; XIANG, ALAN X.; ERNST, JUSTIN T.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 036496/0568 →
Assignment of Assignor's Interest Oct 6, 2016
From: THOMPSON, PEGGY A.; CHEN, WENQIONG JOAN; APPLEMAN, JAMES
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 039960/0825 →
Confirmatory License Oct 24, 2016
From: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
To: NIH-DEITR
Reel/Frame 040100/0885 →
Assignment of Assignor's Interest Oct 27, 2016
From: SPRENGELER, PAUL A; REICH, SIEGFRIED H; ERNST, JUSTIN T; WEBBER, STEPHEN E
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 040500/0449 →
Assignment of Assignor's Interest Nov 2, 2016
From: SPRENGELER, PAUL A.; REICH, SIEGFRIED H.; WEBBER, STEPHEN E.; ERNST, JUSTIN T.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 040193/0634 →
Assignment of Assignor's Interest Nov 15, 2016
From: ERNST, JUSTIN T.; SPRENGELER, PAUL A.; REICH, SIEGFRIED H.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 040323/0414 →
Assignment of Assignor's Interest Nov 15, 2016
From: ERNST, JUSTIN T.; SPRENGELER, PAUL A.; REICH, SIEGFRIED H.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 040320/0944 →
Assignment of Assignor's Interest Nov 16, 2016
From: APPLEMAN, JAMES; THOMPSON, PEGGY A.; HUANG, VERA
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 040347/0902 →
Assignment of Assignor's Interest Nov 17, 2016
From: SPRENGELER, PAUL A.; REICH, SIEGFRIED H.; ERNST, JUSTIN T.; WEBBER, STEPHEN E.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 040356/0001 →
Confirmatory License Mar 17, 2017
From: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042038/0895 →
Confirmatory License Mar 17, 2017
From: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042038/0921 →
Assignment of Assignor's Interest Aug 2, 2017
From: WEBSTER, KEVIN R.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 043176/0094 →
Assignment of Assignor's Interest Aug 8, 2017
From: WEBSTER, KEVIN R.
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 043232/0845 →
Assignment of Assignor's Interest Apr 10, 2018
From: ERNST, JUSTIN T.; SPRENGELER, PAUL A.; REICH, SIEGFRIED H.; SPERRY, SAMUEL
To: EFFECTOR THERAPEUTICS, INC.
Reel/Frame 045582/0559 →